We are live on ! Find out more
T

Tidemark Portfolio holdings

AUM $444M
1-Year Est. Return 19.12%
This Fund
S&P 500
This Quarter Est. Return
+10.29%
1 Year Est. Return
+19.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$444M
AUM Growth
+$50.7M
Cap. Flow
+$16.4M
Cap. Flow %
3.69%
Top 10 Hldgs %
42.54%
Holding
987
New
86
Increased
205
Reduced
142
Closed
52
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JHML icon
301
John Hancock Multifactor Large Cap ETF
JHML
$1.17B
$52.5K 0.01%
588
+2
+0.3% +$172
CMCSA icon
302
Comcast
CMCSA
$96B
$52.2K 0.01%
2,128
-17
-0.8% -$439
SPEM icon
303
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.8B
$52.2K 0.01%
1,007
PM icon
304
Philip Morris
PM
$299B
$51.8K 0.01%
286
+1
+0.4% +$173
EA
305
DELISTED
Electronic Arts
EA
$51.5K 0.01%
251
GSLC icon
306
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.2B
$50.7K 0.01%
358
-8
-2% -$1.11K
HCA icon
307
HCA Healthcare
HCA
$90.5B
$50.7K 0.01%
130
IMRX icon
308
Immuneering
IMRX
$323M
$49.9K 0.01%
10,000
IGSB icon
309
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$49.7K 0.01%
948
RSP icon
310
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$49.1K 0.01%
231
SPTL icon
311
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$11B
$48.6K 0.01%
1,853
-431
-19% -$11.2K
IYW icon
312
iShares US Technology ETF
IYW
$25.3B
$47.9K 0.01%
190
VZ icon
313
Verizon
VZ
$208B
$47.5K 0.01%
1,123
+4
+0.4% +$188
IDNA icon
314
iShares Genomics Immunology and Healthcare ETF
IDNA
$246M
$47.5K 0.01%
1,407
+18
+1% +$540
SHY icon
315
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$47.5K 0.01%
578
+98
+20% +$8.06K
IYH icon
316
iShares US Healthcare ETF
IYH
$3.74B
$47.2K 0.01%
705
BOXX icon
317
Alpha Architect 1-3 Month Box ETF
BOXX
$14.3B
$46.3K 0.01%
+395
New +$46.1K
FENI icon
318
Fidelity Enhanced International ETF
FENI
$11.4B
$46.1K 0.01%
1,148
LQD icon
319
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$45.9K 0.01%
421
ET icon
320
Energy Transfer Partners
ET
$73.4B
$45.9K 0.01%
2,401
-4
-0.2% -$77
RAPP
321
Rapport Therapeutics
RAPP
$2.34B
$45.3K 0.01%
1,088
GBIL icon
322
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.62B
$45K 0.01%
450
+448
+22,400% +$44.8K
ADBE icon
323
Adobe
ADBE
$116B
$44.9K 0.01%
219
+167
+321% +$39.6K
MCD icon
324
McDonald's
MCD
$188B
$43.6K 0.01%
161
-3
-2% -$860
PANW icon
325
Palo Alto Networks
PANW
$303B
$43.3K 0.01%
127

Similar funds

Tidemark's Q2 2026 Portfolio in Review

As of Q2 2026, Tidemark held 987 positions worth $444M, up 13% from $393M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Tidemark deployed $16.4M of net new capital in Q2 2026, opening 86 new positions and adding to 205 existing holdings. Its largest new stake was First Trust Multi-Strategy Alternative ETF: 630,529 shares worth $15.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Invesco S&P 500 Quality ETF, an estimated $8.62M trimmed.

  • Tidemark's largest Q2 2026 buy was First Trust Multi-Strategy Alternative ETF: 630,529 shares worth $15.2M.
  • Tidemark added most to State Street SPDR Portfolio Intermediate Term Treasury ETF in Q2 2026, an estimated $8.6M increase.
  • Tidemark's biggest Q2 2026 reduction was Invesco S&P 500 Quality ETF, cutting an estimated $8.62M.
  • Tidemark fully exited Hologic in Q2 2026, selling an estimated $131K.
  • Tidemark's ten largest holdings make up 43% of its $444M portfolio in Q2 2026.
  • Tidemark opened 86 new positions and closed 52 in Q2 2026.
  • Tidemark's portfolio value rose 13% quarter-over-quarter to $444M.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.